ABBV
Price
$182.31
Change
-$4.48 (-2.40%)
Updated
Jun 27 closing price
Capitalization
322.43B
27 days until earnings call
SCLX
Price
$6.05
Change
+$0.75 (+14.15%)
Updated
Jun 27 closing price
Capitalization
165.55M
Interact to see
Advertisement

ABBV vs SCLX

Header iconABBV vs SCLX Comparison
Open Charts ABBV vs SCLXBanner chart's image
ABBVIE
Price$182.31
Change-$4.48 (-2.40%)
Volume$29.26M
Capitalization322.43B
Scilex Holding
Price$6.05
Change+$0.75 (+14.15%)
Volume$181.52K
Capitalization165.55M
ABBV vs SCLX Comparison Chart in %
Loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABBV vs. SCLX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a Buy and SCLX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ABBV: $182.31 vs. SCLX: $6.05)
Brand notoriety: ABBV: Notable vs. SCLX: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 368% vs. SCLX: 122%
Market capitalization -- ABBV: $322.43B vs. SCLX: $165.55M
ABBV [@Pharmaceuticals: Major] is valued at $322.43B. SCLX’s [@Pharmaceuticals: Major] market capitalization is $165.55M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 3 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).

  • ABBV’s FA Score: 3 green, 2 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, ABBV is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 4 TA indicator(s) are bullish while SCLX’s TA Score has 7 bullish TA indicator(s).

  • ABBV’s TA Score: 4 bullish, 4 bearish.
  • SCLX’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SCLX is a better buy in the short-term than ABBV.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а -1.61% price change this week, while SCLX (@Pharmaceuticals: Major) price change was +23.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.72%. For the same industry, the average monthly price growth was +3.51%, and the average quarterly price growth was +7.73%.

Reported Earning Dates

ABBV is expected to report earnings on Jul 25, 2025.

SCLX is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.72% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABBV($322B) has a higher market cap than SCLX($166M). ABBV YTD gains are higher at: 4.519 vs. SCLX (-59.461). ABBV has higher annual earnings (EBITDA): 17.2B vs. SCLX (-109.1M). ABBV has more cash in the bank: 12.8B vs. SCLX (3.92M). SCLX has less debt than ABBV: SCLX (128M) vs ABBV (59.4B). ABBV has higher revenues than SCLX: ABBV (54.3B) vs SCLX (46.7M).
ABBVSCLXABBV / SCLX
Capitalization322B166M193,976%
EBITDA17.2B-109.1M-15,765%
Gain YTD4.519-59.461-8%
P/E Ratio66.46N/A-
Revenue54.3B46.7M116,274%
Total Cash12.8B3.92M326,447%
Total Debt59.4B128M46,406%
FUNDAMENTALS RATINGS
ABBV: Fundamental Ratings
ABBV
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
13
SMR RATING
1..100
14
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
28

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABBVSCLX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
36%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
50%
Momentum
ODDS (%)
Bearish Trend 1 day ago
40%
Bullish Trend 1 day ago
43%
MACD
ODDS (%)
Bearish Trend 1 day ago
35%
Bullish Trend 1 day ago
44%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 1 day ago
44%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
52%
Bullish Trend 1 day ago
32%
Advances
ODDS (%)
Bullish Trend 16 days ago
56%
Bullish Trend 5 days ago
70%
Declines
ODDS (%)
Bearish Trend 11 days ago
46%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
37%
Aroon
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
22%
View a ticker or compare two or three
Interact to see
Advertisement
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHFS2.230.04
+1.83%
SHF Holdings Inc
PLD105.621.23
+1.18%
PROLOGIS
DDS415.432.20
+0.53%
Dillards
LUNG2.600.01
+0.19%
Pulmonx Corp
GLP52.55-0.43
-0.81%
Global Partners LP

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
-2.40%
PFE - ABBV
54%
Loosely correlated
-0.21%
AMGN - ABBV
48%
Loosely correlated
-0.71%
NVS - ABBV
45%
Loosely correlated
-0.26%
JNJ - ABBV
44%
Loosely correlated
+0.26%
GILD - ABBV
42%
Loosely correlated
+2.83%
More

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and BIIB have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and BIIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
+14.15%
BIIB - SCLX
24%
Poorly correlated
-0.66%
AMRN - SCLX
20%
Poorly correlated
-1.26%
ABBV - SCLX
12%
Poorly correlated
-2.40%
SNY - SCLX
9%
Poorly correlated
-1.03%
RHHVF - SCLX
8%
Poorly correlated
-1.64%
More